PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medicaroid Corporation

USPTO PatentsView assignee record — 80 granted patents across 22 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Explore the portfolio See the ranking
80
Total patents granted
22
CPC technology areas
18.5
Avg claims per patent
+2467%
5-year filing velocity

The verdict

Medicaroid holds 80 US patents across 22 technology areas — rank #4,422 of 50,000 tracked assignees.

#4,422
of 50,000 US assignees by volume
Top 7%
by Innovation Score (55.4/100)
18.5
avg claims per patent
+2467%
filing velocity, last 5 yrs

Portfolio overview

MEDICAROID CORPORATION has been granted 80 US utility patents between 2018 and 2025, placing MEDICAROID CORPORATION at rank #4,422 across all assignees tracked by PlainPatent. This portfolio spans 22 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.5 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, MEDICAROID CORPORATION is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 55.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 77 grants, compared with 3 in the 2015–2019 window — a +2467% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. MEDICAROID CORPORATION's 18.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 22 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark MEDICAROID CORPORATION against peers pursuing similar technology classes.

How does MEDICAROID compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows MEDICAROID holds 80 patents — placing it at rank #4,422 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

MEDICAROID's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

-50510152025 20182019202020212022202320242025 3
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
MEDICAROID CORPORATION patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 2 2.5%
2019 1 1.3%
2020 8 10.0%
2021 17 21.3%
2022 19 23.8%
2023 22 27.5%
2024 8 10.0%
2025 3 3.8%

Which technologies does MEDICAROID CORPORATION patent most?

Top 15 of 22 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#4,422

Across all tracked assignees

Innovation Score

55.4 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does MEDICAROID CORPORATION hold?
MEDICAROID CORPORATION holds 80 US granted patents filed between 2018 and 2025, spanning 22 technology areas.
What is MEDICAROID CORPORATION's Innovation Score?
MEDICAROID CORPORATION has an Innovation Score of 55.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does MEDICAROID CORPORATION focus on?
MEDICAROID CORPORATION's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 74 patents. The company has filed patents in 22 CPC subclasses total.
Is MEDICAROID CORPORATION's patent filing rate increasing or decreasing?
MEDICAROID CORPORATION's recent filing velocity is +2467% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for MEDICAROID CORPORATION's patents?
MEDICAROID CORPORATION's patents average 18.5 claims each. This falls within the standard range, providing solid legal coverage.
How is the MEDICAROID CORPORATION patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

How to use this portfolio

Medicaroid's 80 grants land it in the top 7% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Medicaroid ranks #4,422 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61B — see who else leads that technology area. A61B leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

A61B technology

MEDICAROID CORPORATION's primary CPC class — all holders and yearly trends
Top 50 patent holders

See where MEDICAROID CORPORATION ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov